Humacyte Inc.

0.98
-0.07 (-6.67%)
At close: Mar 03, 2025, 3:57 PM
0.92
-6.50%
After-hours: Mar 03, 2025, 03:58 PM EST

Humacyte Ratios Statement

Year FY23 FY22 FY21 FY20 FY19
PE Ratio -2.65 3.39 7.72 -1.84 -2.28
PEG Ratio 0.01 -0.1 -0.07 -0.06 n/a
PS Ratio n/a 138.94 229.44 84.91 31.45
PB Ratio 21.68 1.86 2.37 -0.36 1.47
P/FCF Ratio -3.89 -3.01 -3.56 -2.27 -2.43
P/OCF Ratio -4.01 -3.06 -3.57 -2.28 -2.71
OCF/S Ratio n/a -45.45 -64.28 -37.27 -11.6
Debt / Equity Ratio 4.25 0.41 0.40 -0.08 0.19
Quick Ratio 4.52 7.88 20.75 3.69 8.76
Current Ratio 4.52 7.88 20.75 3.69 8.76
Asset Turnover n/a 0.01 0.00 0.01 0.04
Interest Coverage -88.38 -13.64 -18.68 -29.34 -37.29
Return on Equity (ROE) -8.18 0.55 0.31 0.20 -0.65
Return on Assets (ROA) -0.86 0.31 0.13 -0.64 -0.51
Return on Capital (ROIC) -0.91 -0.46 -0.29 -0.68 -0.54
Dividend Yield n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a
Gross Profit Margin n/a -427.48% 96.12% -465.53% -1.12K%
Net Profit Margin n/a 4.1K% 2.97K% -4.61K% -1.38K%
Pretax Profit Margin n/a -764.54% -2.1K% -4.46K% -1.38K%
Operating Profit Margin n/a -5.4K% -6.43K% -4.33K% -1.39K%
FCF Margin n/a -4.61K% -6.45K% -3.75K% -1.29K%
EBITDA Margin n/a 159.11% -5.78K% -3.77K% -1.28K%